Prevalence, Risk Factors, and Prognostic Factors of Intraabdominal Hypertension and Abdominal Compartment Syndrome in Critically Ill Surgical Patients in Ramathibodi Hospital

NCT ID: NCT03762057

Last Updated: 2018-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

303 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-10

Study Completion Date

2020-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To identified prevalence, risk factors, and prognostic factors of IAH and ACS in surgical critically ill patients in institutional hospital

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Every postoperative patients admitted to surgical ICU who meet inclusion criteria will be asked for informed consent. After obtained, intraabdominal pressure (IAP) will be measured through already placed Foley's catheter simultaneously with patients's data record. If patients don't have IAH or ICS, IAP will be measured daily until discharge from ICU or removal of Foley's catheter. If patients have IAH or ACS, IAP will be measured every 6-8 hours until IAP is less than 12 mmHg then it will be measures daily until discharge from ICU or removal of Foley's catheter. After completion of data collection, data will be analyzed accordingly.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intraabdominal Hypertension Abdominal Compartment Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgical patients

All postoperative patients admitted to surgical ICU with foley catheter in place

Intraabdominal pressure monitoring

Intervention Type DIAGNOSTIC_TEST

Classic manometry technique measurement once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intraabdominal pressure monitoring

Classic manometry technique measurement once daily

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Postoperative patient admitted to surgical ICU
* Age \>/= 18
* Foley's catheter in place

Exclusion Criteria

* Patient refusal
* Underwent neo-bladder procedure
* Need continuous bladder irrigation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ramathibodi Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cherdkiat karnjanarachata

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cherdkiat Karnjanarachata, MD

Role: PRINCIPAL_INVESTIGATOR

Faculty of medicine, Ramathibodi Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ramathibodi Hospital

Ratchathewi, Bangkok, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cherdkiat Karnjanarachata, MD

Role: CONTACT

+66-85-5774747

Kittikhun Narkasawet, MD

Role: CONTACT

+66-81-6820808

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cherdkiat Karnjanarachata, MD

Role: primary

+66-85-5774747

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CK999

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.